发明名称 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
摘要 Provided are methods for the treatment of disorders of the central nervous system (CNS) and the eye. In particular, use of compositions comprising a compound capable of modulating a target gene or gene product is described for the preparation of a pharmaceutical composition for the treatment of disorders of the CNS and/or the eye, wherein the composition is designed to be administered outside the blood-CNS and the blood-retina barriers. Furthermore, methods are provided for identifying and obtaining nucleic acid molecules encoding polypeptides involved in CNS disorders or of the eye, methods for diagnosing said disorders as well as transgenic animal deficient in the expression of target genes identified in accordance with the described method. In addition, methods of identifying and isolating drugs that are particularly useful for the treatment of disorders related to the CNS and/or the eye are disclosed.
申请公布号 US2012277288(A1) 申请公布日期 2012.11.01
申请号 US201213493690 申请日期 2012.06.11
申请人 DRUMM KARINA;SCHLOR STEFAN HUBERT;GOHRIN FRANK;ACUITY PHARMACEUTICALS, INC. 发明人 DRUMM KARINA;SCHLOR STEFAN HUBERT;GOHRIN FRANK
分类号 A61K31/713;A61K38/17;A61K48/00;A61P9/00;A61P9/10;A61P25/00;A61P25/04;A61P25/06;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P27/02;A61P37/00;A61P43/00;C07H21/02;C12N15/09;C12N15/11;C12N15/113;C12N15/12;C12Q1/02;C12Q1/68;G01N33/15;G01N33/50;G01N33/68 主分类号 A61K31/713
代理机构 代理人
主权项
地址